{"DataElement":{"publicId":"2423296","version":"1","preferredName":"Phase I Trial Dose-Limiting Toxicity Specify","preferredDefinition":"Using the NCI Common Terminology Criteria for Adverse Events (CTCAE) (formerly known as CTC) v2.0 or v3.0 term (see CTEP Home Page for the list of CTCAE terms), provide the specific DLT in the AE_Other_Specify field when 'Other, Specify' is selected from the AE_Type_Code field.","longName":"PHASE_ I_TR_DLT_SPEC","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2422291","version":"1","preferredName":"Phase I Trial Dose-Limiting Toxicity","preferredDefinition":"Side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment in a study involving the first step in testing a new treatment in humans (Phase I Trials test the best way to give a new treatment (e.g., by mouth, intravenous infusion, or injection) and the best dose).","longName":"PHASE_I_TR_DLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2422287","version":"1","preferredName":"Phase I Trial","preferredDefinition":"The first step in testing a new treatment in humans. These studies test the best way to give a new treatment (for example, by mouth, intravenous infusion, or injection) and the best dose. The dose is usually increased a little at a time in order to find the highest dose that does not cause harmful side effects. Because little is known about the possible risks and benefits of the treatments being tested, phase I trials usually include only a small number of patients who have not been helped by other treatments.","longName":"C15600","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Phase I Trial","conceptCode":"C15600","definition":"A clinical research protocol designed to test a new biomedical intervention in a small group of people for the first time. A Phase I trial can be to establish the toxicity of a new treatment with escalating intensity of the treatment administered and/or to determine the side effects of a new treatment for a particular indication in subjects.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0380E320-F5A0-5E13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-10-20","modifiedBy":"ONEDATA","dateModified":"2005-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2422289","version":"1","preferredName":"Dose-Limiting Toxicity","preferredDefinition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.:Toxicity; the degree to which something is poisonous.","longName":"C28014:C27990","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose-Limiting","conceptCode":"C28014","definition":"Describes side effects of a drug or other treatment that are serious enough to prevent an increase in dose or level of that treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0380E320-F5A5-5E13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-10-20","modifiedBy":"ONEDATA","dateModified":"2005-10-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0380E320-F5A6-5E13-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-20","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018370","version":"1","preferredName":"Adverse Event Specify","preferredDefinition":"the free text field to specify an adverse event.","longName":"AE_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30723CB-0BFA-05D8-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-10-11","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"CAMPBELB","dateModified":"2008-03-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2812446","version":"1","longName":"Clinical Data Update System","context":"CTEP"},{"publicId":"2812032","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"}]},{"publicId":"2604617","version":"1","longName":"Submission and Reporting","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000132","version":"1","longName":"Common Terminology Criteria for Adverse Events v3.0","context":"CTEP"},{"publicId":"10000130","version":"1","longName":"Clinical Data Update System","context":"CTEP"},{"publicId":"2812622","version":"1","longName":"Phase 1 End Point","context":"CTEP"}]}],"AlternateNames":[{"name":"PHASE_ I_TR_DLT_SPEC","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"DLT (Adverse Event) Other, Sp","type":"Preferred Question Text","description":"DLT (Adverse Event) Other, Specify","url":null,"context":"CTEP"},{"name":"Source","type":"DATA_ELEMENT_SOURCE","description":"Data element and all values comply with Clinical Data Update System (CDUS) v3.0 Release 2.","url":"http://ctep.cancer.gov/reporting/cdus.html","context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Specify dose-limiting toxicities","url":null,"context":"CTEP"},{"name":"CRF Text2","type":"Alternate Question Text","description":"Specify each dose-limiting toxicity","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"03E16831-AE75-6D9B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-26","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-10-26","modifiedBy":"HARTLEYG","dateModified":"2017-04-05","changeDescription":"05/11/16 Moved to NRDS context as part of NRDS Standardization WG; 04/05/17 Moved to NCIP due to change in scope of NRDS program\r\n","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}